Literature DB >> 921242

Antibiotic concentrations in serum, serum bactericidal activity, and results of therapy of streptococcal endocarditis in rabbits.

J Carrizosa, D Kaye.   

Abstract

The correlation between antibiotic concentrations in serum, serum bactericidal activity, and results of therapy was studied in rabbits with streptococcal endocarditis. Five days of procaine penicillin G reduced bacterial titers to <10 per g in 12 of 14 vegetations in rabbits receiving 75,000 U intramuscularly every 6 h and 10 of 20 in rabbits given 37,500 U. Ten days of 18,750 U every 6 h did not reduce the titers. To test for cure, rabbits were treated with 75,000 U every 6 h for 10 or 20 days and then received no therapy for 7 days. At the end of the 7-day period without therapy, vegetations were sterile in five of five and eight of eight animals, respectively. Rabbits received 37,500 U every 6 h for 5, 10, or 20 days and then no therapy for 7 days, after which vegetations were sterile in one of seven, four of nine, and seven of eight animals, respectively. The median maximal serum bactericidal dilutions at 1 h were 1/16 when 75,000 U of procaine penicillin G was administered, 1/8 to 1/16 with 37,500 U, and 1/4 to 1/8 with 18,750 U. Serum bactericidal activity could not be detected in 50% of the rabbits 6 h after administration of 37,500 U. Cure was related to a median maximal serum bactericidal dilution of at least 1/8 to 1/16 1 h after penicillin administration. A median maximal serum bactericidal dilution of 1/4 to 1/8 resulted in unsuccessful therapy.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 921242      PMCID: PMC429950          DOI: 10.1128/AAC.12.4.479

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

1.  Penicillin-aminoglycoside synergy in experimental Streptococcus viridans endocarditis.

Authors:  M A Sande; R G Irvin
Journal:  J Infect Dis       Date:  1974-05       Impact factor: 5.226

2.  Experimental bacterial endocarditis. 3. Production and progress of the disease in rabbits.

Authors:  D T Durack; P B Beeson; R G Petersdorf
Journal:  Br J Exp Pathol       Date:  1973-04

3.  Gram-negative bacillary endocarditis. Interpretation of the serum bactericial test.

Authors:  C S Bryan; S R Marney; R H Alford; R E Bryant
Journal:  Am J Med       Date:  1975-02       Impact factor: 4.965

4.  Role of the vegetation in experimental Streptococcus viridans endocarditis.

Authors:  E W Hook; M A Sande
Journal:  Infect Immun       Date:  1974-12       Impact factor: 3.441

5.  Chemotherapy of experimental streptococcal endocarditis. II. Synergism between penicillin and streptomycin against penicillin-sensitive streptococci.

Authors:  D T Durack; L L Pelletier; R G Petersdorf
Journal:  J Clin Invest       Date:  1974-03       Impact factor: 14.808

6.  Antagonism between chloramphenicol and penicillin in streptococcal endocarditis in rabbits.

Authors:  J Carrizosa; W D Kobasa; D Kaye
Journal:  J Lab Clin Med       Date:  1975-02

7.  Chemotherapy of experimental streptococcal endocarditis. V. Effect of duration of infection and retained intracardiac catheter on response to treatment.

Authors:  L L Pelletier; R G Petersdorf; K Nielson
Journal:  J Lab Clin Med       Date:  1976-04

8.  Clinical and in vitro evaluation of cefazolin, a new cephalosporin antibiotic.

Authors:  K Ries; M E Levison; D Kaye
Journal:  Antimicrob Agents Chemother       Date:  1973-02       Impact factor: 5.191

  8 in total
  8 in total

1.  Antibiotic efficacy is linked to bacterial cellular respiration.

Authors:  Michael A Lobritz; Peter Belenky; Caroline B M Porter; Arnaud Gutierrez; Jason H Yang; Eric G Schwarz; Daniel J Dwyer; Ahmad S Khalil; James J Collins
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-22       Impact factor: 11.205

2.  Serum bactericidal titer as a predictor of outcome in endocarditis.

Authors:  C J Hackbarth; H F Chambers; M A Sande
Journal:  Eur J Clin Microbiol       Date:  1986-02       Impact factor: 3.267

Review 3.  Value of the serum bactericidal test in management of patients with bacterial endocarditis.

Authors:  J W Mellors; D L Coleman; V T Andriole
Journal:  Eur J Clin Microbiol       Date:  1986-02       Impact factor: 3.267

4.  Prophylaxis against enterococcal endocarditis: comparison of the aminoglycoside component of parenteral antimicrobial regimens.

Authors:  J Murillo; H C Standiford; H P Holley; B A Tatem; E S Caplan
Journal:  Antimicrob Agents Chemother       Date:  1980-09       Impact factor: 5.191

5.  Comparative study of anti-pseudomonas activity of azlocillin, mezlocillin, and ticarcillin.

Authors:  L Coppens; J Klastersky
Journal:  Antimicrob Agents Chemother       Date:  1979-03       Impact factor: 5.191

6.  Rat model of experimental endocarditis.

Authors:  J Santoro; M E Levison
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

7.  Vancomycin or vancomycin plus netilmicin for methicillin- and gentamicin-resistant Staphylococcus aureus aortic valve experimental endocarditis.

Authors:  G Perdikaris; H Giamarellou; A Pefanis; I Donta; P Karayiannakos
Journal:  Antimicrob Agents Chemother       Date:  1995-10       Impact factor: 5.191

8.  Cefoperazone treatment of experimental endocarditis.

Authors:  R A Snepar; J Carrizosa; W D Kobasa; D Kaye
Journal:  Antimicrob Agents Chemother       Date:  1981-05       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.